PhaseBio Pharmaceuticals, Inc. (PHASQ)
OTCMKTS: PHASQ · Delayed Price · USD
0.0000
0.00 (0.00%)
May 15, 2024, 10:52 AM EDT - Market closed
PhaseBio Pharmaceuticals Market Cap
PhaseBio Pharmaceuticals has a market cap or net worth of $50.00 as of July 2, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
50.00
Enterprise Value
-2.43M
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since October 18, 2018, PhaseBio Pharmaceuticals's market cap has decreased from $97.90M to $50.00, a decrease of -100.00%. That is a compound annual growth rate of -97.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2022 | 3.50M | -97.21% |
| Dec 31, 2021 | 125.50M | 27.15% |
| Dec 31, 2020 | 98.70M | -43.86% |
| Dec 31, 2019 | 175.80M | 132.23% |
| Dec 31, 2018 | 75.70M | -22.68% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 861.74B |
| Novo Nordisk | 628.28B |
| UnitedHealth Group | 458.57B |
| Johnson & Johnson | 351.45B |
| Merck & Co. | 323.49B |
| AbbVie | 293.06B |
| AstraZeneca | 238.71B |
| Novartis AG | 208.25B |